News
- The FDA grants Priority Review designation for the evaluation of medicines that, if approved, would provide a significant ...
SKYTROFA® (lonapegsomatropin) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of paediatric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback